Clinical Trials List
2009-02-01 - 2017-05-28
Phase III
Terminated3
Suspended4
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 李忠恕 Division of Thoracic Medicine
- Chih-Liang Wang Division of Thoracic Medicine
- Ping-Chih Hsu Division of Thoracic Medicine
- Meng-Jer Hsieh Division of Thoracic Medicine
- Chien-Ying Liu Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- Ying-Huang Tsai Division of Thoracic Medicine
- 林玠模 Division of Thoracic Medicine
- 林進國 Division of Thoracic Medicine
- 洪明賜 Division of Thoracic Medicine
- 楊聰明 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 趙東瀛 Division of Thoracic Medicine
- 張晃智 Division of Thoracic Medicine
- 王逸熙 Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- 劉世豐 Division of Thoracic Medicine
- 賴建豪 Division of Thoracic Medicine
- 蘇茂昌 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 曹朝榮 Division of Hematology & Oncology
- 林明賢 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 陳威宇 Division of Hematology & Oncology
- 林正耀 Division of Hematology & Oncology
- Shang-Hung Chen Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 陳昭勳 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 吳杰鴻 Division of Thoracic Medicine
- Jen-Fu Shih Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Suspended
Co-Principal Investigator
- 葉本芳 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Suspended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
240 participants
-
Global
382 participants
